Variant report
Variant | nsv1037130 |
---|---|
Chromosome Location | chr12:73424263-73444590 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532004920 | chr12:73424280-73424281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147968411 | chr12:73424291-73424292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553579589 | chr12:73424305-73424306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537790848 | chr12:73424320-73424321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555782716 | chr12:73424372-73424373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182230526 | chr12:73424373-73424374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187539939 | chr12:73424383-73424384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534865411 | chr12:73424386-73424387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192470813 | chr12:73424434-73424435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141869757 | chr12:73424447-73424448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545501314 | chr12:73424455-73424456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185710211 | chr12:73424469-73424470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575545134 | chr12:73424495-73424496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs75658327 | chr12:73425229-73425230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557442627 | chr12:73425270-73425271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149583919 | chr12:73425375-73425376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536215306 | chr12:73425411-73425412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563352829 | chr12:73425447-73425448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554867461 | chr12:73425485-73425486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111264677 | chr12:73425489-73425490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs61933273 | chr12:73425542-73425543 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs540123411 | chr12:73425561-73425562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372924437 | chr12:73425571-73425572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564780262 | chr12:73425580-73425581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377261318 | chr12:73425612-73425613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192951194 | chr12:73425626-73425627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370091666 | chr12:73425628-73425629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566144073 | chr12:73425629-73425630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534830454 | chr12:73425654-73425655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs116237178 | chr12:73425729-73425730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529708747 | chr12:73425736-73425737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547904426 | chr12:73425755-73425756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560077988 | chr12:73425756-73425757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571758520 | chr12:73425758-73425759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528833017 | chr12:73425761-73425762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547309064 | chr12:73425778-73425779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187228027 | chr12:73435040-73435041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11179520 | chr12:73435084-73435085 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs531676927 | chr12:73435155-73435156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528820440 | chr12:73435185-73435186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549760254 | chr12:73435222-73435223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548868734 | chr12:73435269-73435270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192552724 | chr12:73435288-73435289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184359751 | chr12:73435292-73435293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547536714 | chr12:73435403-73435404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553777071 | chr12:73435458-73435459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565809844 | chr12:73435478-73435479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539144960 | chr12:73435528-73435529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557776139 | chr12:73435565-73435566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569548085 | chr12:73435591-73435592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16620391 | CNVD |
Disease | 21505450 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17133270 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Osteosarcoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:73424200-73424600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr12:73425200-73425800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr12:73435000-73435800 | Enhancers | HUES48 Cell Line | embryonic stem cell |